Application of mPGES-2 as drug target for treating and/or preventing diabetes mellitus
A technology for diabetes, type 1 diabetes, applied in the field of biomedicine
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0028] The present invention will be described in further detail below in conjunction with the accompanying drawings and specific embodiments.
[0029] The experimental methods used in the following examples are conventional methods unless otherwise specified.
[0030] Materials, reagents, etc. used in the following examples, unless otherwise specified, can be obtained from commercial sources, for example:
[0031] Experimental animals: mPGES-2 heterozygous mice used in this example were obtained by Jiangsu Jicui Yaokang Biotechnology Co., Ltd. using Crispr Cas9 technology, and bred at Xuzhou Medical University to obtain mPGES-2 wild-type (WT) mice and mPGES- 2 Knockout (KO) mice. The mouse-derived mPGES-2 overexpression plasmid was purchased from Hanbio Technology Co., Ltd., and was wrapped by adeno-associated virus (AAV). mPGES-2 overexpression control mice (CON) and mPGES-2 overexpression mice (OVER) were adaptively fed by C57BL / 6 mice for one week, and 100 μL of AAV cont...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com